Focus on production innovation, evolving regulations, and growing demand in animal feed and human nutrition to capture market opportunities in the choline chloride sector Choline Chloride Market ...
Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that patient dosing is now ...
Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of ...
On track to report interim results from approximately 25 six-month evaluable BCG-Unresponsive patients in ADVANCED-2 trial in Q1 2026Received ...
(MENAFN- GlobeNewsWire - Nasdaq) NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment ...
(RTTNews) - Protara Therapeutics, Inc. (TARA) has dosed the first patient in its pivotal Phase 3 registrational THRIVE-3 trial evaluating intravenous (IV) Choline Chloride in patients dependent on ...
A clinical-stage biotechnology company headquartered in New York, United States. The company runs clinical development through external trial sites in the United States and other regions, depending on ...
A team of researchers has demonstrated a cutting-edge plant-based plastic bag that can dissolve in water without producing ...
AZoCleantech on MSN
Plant-based plastic is adjustable, flexible, and easily decomposes
A new biodegradable plastic from plant cellulose breaks down in seawater without microplastics. It may be a sustainable solution to conventional plastics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback